Artwork

Content provided by The Pulse by Wharton Digital Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Pulse by Wharton Digital Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Mark Cuban, Mark Cuban Cost Plus Drug Company, on bringing transparency to pharmacy

44:39
 
Share
 

Manage episode 361057240 series 2587257
Content provided by The Pulse by Wharton Digital Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Pulse by Wharton Digital Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Our guest on this episode is Mark Cuban. In addition to a storied business career that includes owning the NBA's Dallas Mavericks and a role on ABC's Shark Tank, Mark is the founder and lead investor in the Mark Cuban Cost Plus Drug Company, a generic pharmaceutical distributor that prices medications at cost, plus a 15% administrative markup and any relevant pharmacy and shipping fees. Founded in early 2022, over 1.7M patients have signed up for the service in their first year, and Cost Plus Drugs now offers over 1,000 generic medications for purchase on their website. Mark founded the company with CEO Dr. Alex Oshmyansky, a pediatric radiologist who originally tried to start an organization similar to Cost Plus Drugs as a non-profit, before pivoting and convincing Mark to be his partner. In this episode, I spoke with Mark about his journey to starting Cost Plus Drugs, how the company is able to drive down prices so drastically compared to the existing players, and how incumbents, such as traditional pharmacy benefit managers and new entrants, such as the Amazon RxPass, will impact the success of Cost Plus Drugs.
  continue reading

111 episodes

Artwork
iconShare
 
Manage episode 361057240 series 2587257
Content provided by The Pulse by Wharton Digital Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Pulse by Wharton Digital Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Our guest on this episode is Mark Cuban. In addition to a storied business career that includes owning the NBA's Dallas Mavericks and a role on ABC's Shark Tank, Mark is the founder and lead investor in the Mark Cuban Cost Plus Drug Company, a generic pharmaceutical distributor that prices medications at cost, plus a 15% administrative markup and any relevant pharmacy and shipping fees. Founded in early 2022, over 1.7M patients have signed up for the service in their first year, and Cost Plus Drugs now offers over 1,000 generic medications for purchase on their website. Mark founded the company with CEO Dr. Alex Oshmyansky, a pediatric radiologist who originally tried to start an organization similar to Cost Plus Drugs as a non-profit, before pivoting and convincing Mark to be his partner. In this episode, I spoke with Mark about his journey to starting Cost Plus Drugs, how the company is able to drive down prices so drastically compared to the existing players, and how incumbents, such as traditional pharmacy benefit managers and new entrants, such as the Amazon RxPass, will impact the success of Cost Plus Drugs.
  continue reading

111 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide